Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya.
about
Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Risk of Injection-Site Abscess ...... al Conjugate Vaccine in Kenya.
@ast
Risk of Injection-Site Abscess ...... al Conjugate Vaccine in Kenya.
@en
type
label
Risk of Injection-Site Abscess ...... al Conjugate Vaccine in Kenya.
@ast
Risk of Injection-Site Abscess ...... al Conjugate Vaccine in Kenya.
@en
prefLabel
Risk of Injection-Site Abscess ...... al Conjugate Vaccine in Kenya.
@ast
Risk of Injection-Site Abscess ...... al Conjugate Vaccine in Kenya.
@en
P2093
P2860
P50
P1433
P1476
Risk of Injection-Site Abscess ...... al Conjugate Vaccine in Kenya.
@en
P2093
Allan O Audi
Beatrice Olack
Deron C Burton
Dominic Ouma
Evasius Bauni
George A Otieno
Godfrey M Bigogo
Isaac Mugoya
J Anthony G Scott
Jackline Wafula
P2860
P304
P356
10.1371/JOURNAL.PONE.0141896
P407
P577
2015-10-28T00:00:00Z